What Researchers Did
Researchers described the successful treatment of a 20-year-old diabetic patient suffering from a severe fungal infection called rhino-orbital mucormycosis, which included adjunctive hyperbaric oxygen therapy.
What They Found
A 20-year-old male with poorly controlled type 1 diabetes presented with facial swelling and necrotic nasal lesions, diagnosed as rhino-orbital mucormycosis. His treatment involved multiple surgical debridements, dual antifungal therapy with liposomal amphotericin B and isavuconazole, and adjunctive hyperbaric oxygen therapy. Despite severe complications including septic and cardiogenic shock, the patient achieved clinical and radiological stability, maintained for over two years with suppressive isavuconazole therapy.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a case report, this study describes the experience of a single patient, meaning its findings cannot be broadly applied to all patients with mucormycosis.